No Data
No Data
FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids Using Fibroblast Cell-Based Technology
FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Hoth Therapeutics HOTH +81% Released Data; FibroBiologics FBLG +22% Analyst
EF Hutton Initiates FibroBiologics(FBLG.US) With Buy Rating, Announces Target Price $16
Express News | EF Hutton Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $16
FibroBiologics Analyst Ratings
No Data
No Data